Abstract
The prevalence of extended-spectrum beta-lactamase (ESBL) production by consecutive non-repeated isolates of Enterobacteriaceae was determined over a 6-month period. A total of 8015 strains were isolated from ten Italian laboratories and 509 (6.3%) of these were designated ESBL producers from the results of a double-disk synergy test. Escherichia coli was the most isolated microrganism, followed by Klebsiella pneumoniae and Proteus mirabilis. Providencia stuartii (28.1%) was the most frequently isolated ESBL producer, followed by K. pneumoniae and Enterobacter aerogenes (20.5%). However, amongst all ESBL producers, K. pneumoniae (38.2%) was the most represented followed by P. mirabilis (25.7%). All the strains positive to DD tests were confirmed for the carriage of TEM and SHV genes using colony-blot hybridisation (CH). A total of 447 strains (88.0%) were CH-positive, of which 42.3% hybridised with the TEM-type probe, 30.1% with the SHV-type probe and 15.6% with both probes. In conclusion, our findings indicate that 6.3% of all Enterobacteriaceae tested produced ESBLs, 42.3% of which were TEM-derived enzymes. More than 20% of P. stuartii, K. pneumoniae and E. aerogenes harbour these enzymes. The double-disk test seems to be a u...Continue Reading
References
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·K S Thomson, C C Sanders
Jul 1, 1988·Reviews of Infectious Diseases·V JarlierA Philippon
Nov 1, 1983·Infection·H KnotheS Mitsuhashi
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Oct 1, 1993·The Journal of Antimicrobial Chemotherapy·F W GoldsteinL Gutmann
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·D Sirot
Mar 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A MarcheseA Philippon
Sep 1, 1996·The Journal of Antimicrobial Chemotherapy·D M Livermore, M Yuan
Feb 1, 1997·The Journal of Antimicrobial Chemotherapy·L J PiddockP M Hawkey
Jan 7, 2000·Infection·E E StobberinghJ H van Zeijl
Feb 8, 2000·The Journal of Antimicrobial Chemotherapy·G S Babini, D M Livermore
Mar 7, 2000·The Journal of Antimicrobial Chemotherapy·Y LaksaiS Stefani
Jun 27, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M PereiraG Amicosante
Aug 10, 2000·International Journal of Antimicrobial Agents·G NicolettiF Paradisi
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·M PerilliG Amicosante
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·C De ChampsJ Sirot
Feb 24, 2001·Antimicrobial Agents and Chemotherapy·F Doucet-PopulaireJ Sirot
Feb 5, 2002·Journal of Clinical Microbiology·Mariagrazia PerilliGianfranco Amicosante
Citations
Apr 15, 2004·Indian Journal of Pediatrics·Jocelyn Y AngBasim I Asmar
Aug 21, 2003·International Journal of Antimicrobial Agents·Xavier BertrandD Talon
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Jacob SchlesingerYehuda Carmeli
Mar 16, 2005·Chemotherapy·Agata LanzafameRoberto Mattina
Apr 5, 2005·Indian Journal of Medical Sciences·Rashmi SharmaBhuvneshwar Kapoor
Jul 14, 2004·Research in Microbiology·Aamer Ali ShahAbdul Hameed
Nov 26, 2008·Journal of Chemotherapy·S StefaniG Nicoletti
Jun 26, 2004·Journal of Chemotherapy·E CarrettoP Marone
Aug 31, 2004·Journal of Chemotherapy·G BaharZ Gülay
Apr 15, 2005·Journal of Chemotherapy·L DragoM R Gismondo
Jul 16, 2003·Current Opinion in Infectious Diseases·Rafael CantónFernando Baquero